| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $8.2M | — | +20.9% |
| R&D Expense | $624K | — | -56.6% |
| SG&A Expense | $6.6M | — | -37.1% |
| Operating Income | -$6.1M | — | +47.5% |
| Pre-tax Income | -$6.5M | — | -46.0% |
| Income Tax | $0 | — | -100.0% |
| Net Income | -$6.5M | — | -45.1% |
| EPS (Basic) | -$0.12 | — | -20.0% |
| EPS (Diluted) | -$0.12 | — | -20.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $10.1M | -31.3% | -64.1% |
| Accounts Receivable | $1.9M | +18.5% | +186.6% |
| Current Assets | $27.4M | -13.7% | -29.2% |
| Total Assets | $54.4M | -8.9% | -17.8% |
| Current Liabilities | $16.2M | +3.6% | +89.5% |
| Total Liabilities | $46.0M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$4.1M | — | +35.8% |
| Investing Cash Flow | -$1.4M | — | +24.7% |
| Financing Cash Flow | $1.2M | — | +1757.1% |
| +14.7% |
| Stockholders' Equity | $8.3M | -38.0% | -68.0% |